IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

Completed

• Conditions: High Blood Pressure

• Registration Number: NCT00416611
• Lead Sponsor: Hellenic Atherosclerosis Society

Brief Summary

The objective of this protocol is to improve awareness, treatment, and control of arterial hypertension, within primary prevention of target organ damage, by implementing guidelines, after training of the participating physicians.

Detailed Description

Physicians from 20 hospitals and 40 health centres (primary health care settings) were trained to implement guidelines in treating arterial hypertension.

There will be a baseline recording of patients with arterial hypertension and then physicians will have to complete a one page form (by ticking pre-specified boxes) about the baseline status of the patients and will have to report the measures they took to improve awareness, treatment, and effective control of arterial hypertension. After a six month effort, physicians will have to complete the same form at study completion. Previous training of physicians and the fact that they will have to report their success in treating hypertension will hopefully contribute to an increase in number of hypertensive patients at blood pressure target, and will minimise the target organ damage. The estimated reduction in coronary heart disease risk will be evaluated by a comparison of this risk (as evaluated by a risk engine, i.e. PROCAM) at study completion with that of baseline.

Study Timeline

• Study Start: 2006-11
• Study First Submitted: 2006-12-23
• Study First Submitted QC: 2006-12-27
• Study First Posted: 2006-12-28
• Primary Completion: 2007-11
• Study Completion: 2007-11
• Status Verified: 2009-01
• Last Update Submitted: 2009-01-28
• Last Update Posted: 2009-01-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Arterial hypertension as defined by the JNC 7 report

Exclusion Criteria

• Pregnancy
• Lactation
• Malignancies with small life expectancy
• Unwillingness to participate

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficacy in arterial hypertension control	6 months
Efficacy in reducing estimated risk of coronary heart disease	6 months

Secondary Outcome Measures

Name	Time	Method
Cost effectiveness of arterial hypertension control	6 months
Differences between primary and secondary health care settings as well as teaching hospitals	6 months

Trial Locations

Locations (1)

Hellenic Atherosclerosis Society; 🇬🇷 Thessaloniki, Greece